AIDS 2012: Once-daily Maraviroc + Boosted Atazanavir Looks Promising at 96 Weeks
- Details
- Category: Approved HIV Drugs
- Published on Wednesday, 25 July 2012 00:00
- Written by Liz Highleyman
A NRTI-sparing regimen of maraviroc (Selzentry) plus ritonavir-boosted atazanavir (Reyataz) produced good virological suppression and was generally well tolerated through 96 weeks, according to a study presented Tuesday at the XIX International AIDS Conference (AIDS 2012) in Washington, DC.
AIDS 2012: We Can End AIDS, Activists Declare [VIDEO]
- Details
- Category: HIV Policy & Advocacy
- Published on Wednesday, 25 July 2012 00:00
- Written by Gregory Fowler
About 5000 activists marched from the Walter E. Washington Convention Center to the White House on July 24, 2012, demanding more resources and sound public policies in the fight against HIV/AIDS.
Five marches converged at Lafayette Park, where several speakers addressed a rally and a dozen protesters were arrested typing red ribbons to the White House fence.
AIDS 2012: Barbara Lee -- HIV Funding Is a Matter of Priorities [VIDEO]
- Details
- Category: HIV Policy & Advocacy
- Published on Tuesday, 24 July 2012 00:00
- Written by Gregory Fowler
The current government climate is focused on cutting the safety net, Rep. Barbara Lee (D-Calif, 9th District) said July 22, 2012, at the opening press conference and plenary at the XIX International AIDS Conference (AIDS 2012), taking place in Washington, DC. "We have the resources, but we can't get the political consensus."
Sex Workers and Drug Users Interrupt Business as Usual at AIDS 2012
- Details
- Category: People Who Inject Drugs
- Published on Tuesday, 24 July 2012 00:00
- Written by Cyd Nova
Holding red umbrellas -- the international symbol of sex worker rights -- and chanting "Nothing About Us, Without Us!" sex workers and drug users disrupted the opening of the 19th International AIDS Conference (AIDS 2012), taking place this week in Washington, DC.
Fewer People Maintain HIV Viral Suppression than Previously Thought
- Details
- Category: HIV Treatment
- Published on Tuesday, 24 July 2012 00:00
- Written by Press Release
While the proportion of patients who achieve undetectable viral load on antiretroviral therapy (ART) has increased over the past decade, in 2008-2010 only about 70% maintained viral suppression over the course of a year, researchers reported in the July 25, 2012, HIV theme issue of the Journal of the American Medical Association coinciding with the XIX International AIDS Conference (AIDS 2012) this week in Washington, DC.
Web Design and Development by